152402-97-6 Usage
General Description
4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride is a chemical compound with the molecular formula C7H8Cl2N. It is a white to off-white crystalline solid that is soluble in water and organic solvents. 4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride is used in the synthesis of pharmaceuticals and agrochemicals. It is also used as a reagent in chemical reactions. 4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride is a potential irritant and should be handled with care. Its precise properties and applications make it a valuable component in various industrial processes.
Check Digit Verification of cas no
The CAS Registry Mumber 152402-97-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,4,0 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 152402-97:
(8*1)+(7*5)+(6*2)+(5*4)+(4*0)+(3*2)+(2*9)+(1*7)=106
106 % 10 = 6
So 152402-97-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H7Cl2N.ClH/c1-5-6(9)2-3-10-7(5)4-8;/h2-3H,4H2,1H3;1H
152402-97-6Relevant articles and documents
Identification and synthesis of potential impurities of rabeprazole sodium
Pingili, R. Reddy,Jambula, M. Reddy,Ganta, M. Reddy,Ghanta, M. Reddy,Sajja,Sundaram,Boluggdu, V. Bhaskar
, p. 814 - 818 (2007/10/03)
Rabeprazole sodium (1, Achiphex) is a gastric proton pump inhibitor. It causes dose-dependent inhibition of acid secretion and is useful as an anti-ulcer agent. In the process for the preparation of 1, two potential unknown impurities were identified in HPLC at levels ranging from 0.05-0.8%. Based on mass spectral data vide LC-MS, the two impurities were characterized as 2-{[(4-chloro-3-methyl-2-pyridinyl) methyl] sulfinyl}-1H-bezimidazole (2, chloro analogue of rabeprazole) and 2-[{(4-methoxy-3-methyl-2-pyridinyl)methyl} sulfinyl]-1H-benzimidazole (3, methoxy analogue of rabeprazole). The structures were unambiguously established by independently synthesizing them and co-injecting in HPLC. To our knowledge, the compounds 2 and 3 have not been reported as process impurities elsewhere.